Full Press Release Details
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) will announce results for the second quarter of 2026 on Thursday, July 30, 2026. Company executives will review financial results with the investment community during a conference call beginning at 8:15 a.m. ET.
Investors and the general public are invited to listen to a live audio webcast of the call athttp://investor.bms.com. Materials related to the call will be available on the company’sInvestor Relations websiteprior to the start of the conference call.
A replay of the webcast will be availablehereapproximately three hours after the conference call concludes.
About Bristol Myers Squibb: Transforming Patients’ Lives Through ScienceAt Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what’s possible for the future of medicine and the patients we serve. For more information, visit us atBMS.comand follow us onLinkedIn,X,YouTube,FacebookandInstagram.
corporatefinancial-news